2026 flu vaccine order for perry point VA medical center.

Ended Awarded

Contract number
36C24526N0412
Awardee
Awarding agency
Obligated
$55,997

Award facts

Contract value 100% obligated
$55,996.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Summit, NJ 07901, USA

Award details come from SAM.gov/FPDS.

About this award

This delivery order, awarded on March 18, 2026, represents a $55,996.80 firm fixed-price contract for 2026 flu vaccine procurement to support the Perry Point Veterans Affairs Medical Center. The order was issued by Veterans Integrated Service Network 5 (VISN 5), which is part of the Department of Veterans Affairs' healthcare delivery system. Seqirus USA Inc., a biotechnology company headquartered in Summit, New Jersey, was selected as the prime contractor. The contract contains no set-aside designation, indicating a competitive award. The vaccine delivery is scheduled to be completed by October 15, 2026, with the place of performance in Summit, New Jersey, where the contractor manufactures its influenza vaccine products.

This delivery order is issued under a larger indefinite delivery contract vehicle. The VA National Acquisition Center awarded Seqirus a single-award indefinite delivery contract valued at $30.9 million for the 2026-2027 flu season, which serves as the primary procurement mechanism enabling federal agencies to issue task orders on an as-needed basis throughout each flu season. Seqirus is an established federal contractor since 2008 and a critical supplier of seasonal influenza vaccination products across multiple government agencies, including the Department of Justice Bureau of Prisons, the Indian Health Service, the Defense Logistics Agency, and the Centers for Disease Control and Prevention. The company's product portfolio includes quadrivalent vaccines, multi-dose vials, pre-filled syringes, and specialized high-dose formulations designed for specific populations such as elderly individuals.

Quick answers

Who was awarded contract 36C24526N0412?

36C24526N0412 was awarded to Seqirus USA Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 18, 2026.

How much is contract 36C24526N0412 worth?

The government has obligated $55,997 on 36C24526N0412.

Is contract 36C24526N0412 an order under another contract?

Yes. 36C24526N0412 is a delivery order under 36E79726D0010, an indefinite delivery contract.

Was contract 36C24526N0412 competed?

The extent of competition for 36C24526N0412 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award